Sandbox ID Upper Respiratory Tract: Difference between revisions

Jump to navigation Jump to search
← Older editNewer edit →
VisualWikitext
Gerald Chi- (talk | contribs)
Bureaucrats, bureaucrats, nocaptcha, oversight, smwadministrator, Administrators, Widget editors
7,699 edits
Gerald Chi- (talk | contribs)
Bureaucrats, bureaucrats, nocaptcha, oversight, smwadministrator, Administrators, Widget editors
7,699 edits
Line 80: Line 80:
:* Preferred regimen (immunocompetent host): ([[Penicillin G]] 2–4 MU IV q4–6h {{and}} [[Tobramycin]] 2 mg/kg IV q8h) {{or}} [[Ampicillin-Sulbactam]] 2 g IV q4h {{or}} [[Clindamycin]] 600 mg IV q6h {{or}} [[Doxycycline]] 200 mg IV q12h {{or}} [[Cefoxitin]] 2 g IV q6h {{or}} [[Cefotetan]] 2 g IV q12h  
:* Preferred regimen (immunocompetent host): ([[Penicillin G]] 2–4 MU IV q4–6h {{and}} [[Tobramycin]] 2 mg/kg IV q8h) {{or}} [[Ampicillin-Sulbactam]] 2 g IV q4h {{or}} [[Clindamycin]] 600 mg IV q6h {{or}} [[Doxycycline]] 200 mg IV q12h {{or}} [[Cefoxitin]] 2 g IV q6h {{or}} [[Cefotetan]] 2 g IV q12h  
:* Preferred regimen (immunocomppromised host): [[Cefotaxime]] 2 g IV q6h {{or}} [[Ceftizoxime]] 4 g IV q8h {{or}} [[Piperacillin]] 3 g IV q4h {{or}} Imipenem 500 mg IV q6h {{or}} [[Meropenem]] 1 g IV q8h {{or}} [[Gatifloxacin]] 200 mg IV q24h
:* Preferred regimen (immunocomppromised host): [[Cefotaxime]] 2 g IV q6h {{or}} [[Ceftizoxime]] 4 g IV q8h {{or}} [[Piperacillin]] 3 g IV q4h {{or}} Imipenem 500 mg IV q6h {{or}} [[Meropenem]] 1 g IV q8h {{or}} [[Gatifloxacin]] 200 mg IV q24h
* '''Lateral pharyngeal or retropharyngeal space infections (odontogenic)'''
:* Causative pathogens
::* Viridans and other streptococci
::* Staphylococcus
::* Peptostreptococcus
::* Bacteroides
::* Other oral anaerobes
:* Preferred regimen (immunocompetent host): ([[Penicillin G]] 2–4 MU IV q4–6h {{and}} [[Metronidazole]] 0.5 g IV q6h) {{or}} [[Ampicillin-Sulbactam]] 2 g IV q4h {{or}} [[Clindamycin]] 600 mg IV q6h
:* Preferred regimen (immunocomppromised host): [[Cefotaxime]] 2 g IV q6h {{or}} [[Ceftizoxime]] 4 g IV q8h {{or}} [[Piperacillin]] 3 g IV q4h {{or}} Imipenem 500 mg IV q6h {{or}} [[Imipenem]] 500 mg IV q6h {{or}} [[Gatifloxacin]] 400 mg IV q24h
* '''Lateral pharyngeal or retropharyngeal space infections (rhinogenic)'''
:* Causative pathogens
::* Streptococcus pyogenes
::* Fusobacterium
::* Peptostreptococcus
::* Other oral anaerobes
:* Preferred regimen (immunocompetent host): [[Penicillin G]] 2–4 MU IV q4–6h {{or}} ([[Ciprofloxacin]] 200 mg q12h {{and}} [[Metronidazole]] 0.5 g IV q6h) {{or}} [[Gatifloxacin]] 400 mg IV q24h {{or}} [[Clindamycin]] 600 mg IV q6h
:* Preferred regimen (immunocomppromised host): [[Cefotaxime]] 2 g IV q6h {{or}} [[Ceftizoxime]] 4 g IV q8h {{or}} [[Piperacillin]] 3 g IV q4h {{or}} Imipenem 500 mg IV q6h {{or}} [[Imipenem]] 500 mg IV q6h {{or}} [[Gatifloxacin]] 400 mg IV q24h
* '''Lateral pharyngeal or retropharyngeal space infections (otogenic)'''
:* Causative pathogens
::* Streptococcus pneumoniae
::* Haemophilus influenzae
::* Viridans and other streptococci
::* Peptostreptococcus
::* Bacteroides
::* Other oral anaerobes
:* Preferred regimen (immunocompetent host): [[Penicillin G]] 2–4 MU IV q4–6h {{or}} ([[Ciprofloxacin]] 200 mg q12h {{and}} [[Metronidazole]] 0.5 g IV q6h) {{or}} [[Gatifloxacin]] 400 mg IV q24h {{or}} [[Clindamycin]] 600 mg IV q6h
:* Preferred regimen (immunocomppromised host): [[Cefotaxime]] 2 g IV q6h {{or}} [[Ceftizoxime]] 4 g IV q8h {{or}} [[Piperacillin]] 3 g IV q4h {{or}} Imipenem 500 mg IV q6h {{or}} [[Imipenem]] 500 mg IV q6h {{or}} [[Gatifloxacin]] 400 mg IV q24h
* '''Peritonsillar abscess (quinsy)'''
:* Causative pathogens
::* Viridans and other streptococci
::* Peptostreptococcus
::* Bacteroides
::* Other oral anaerobes
:* Preferred regimen (immunocompetent host): ([[Penicillin G]] 2–4 MU IV q4–6h {{and}} [[Metronidazole]] 0.5 g IV q6h) {{or}} [[Ampicillin-Sulbactam]] 2 g IV q4h {{or}} [[Clindamycin]] 600 mg IV q6h {{or}} [[Cefoxitin]] 2 g IV q6h
:* Preferred regimen (immunocomppromised host): [[Cefotaxime]] 2 g IV q6h {{or}} [[Ceftizoxime]] 4 g IV q8h {{or}} [[Piperacillin]] 3 g IV q4h
* '''Suppurative parotitis'''
:* Causative pathogens
::* Staphylococcus
::* Viridans and other streptococci
::* Bacteroides
::* Peptostreptococcus
::* Other oral anaerobes
:* Preferred regimen (immunocompetent host): ([[Nafcillin]] 1.5 g IV q4–6h {{and}} [[Metronidazole]] 0.5 g IV q6h) {{or}} [[Clindamycin]] 600 mg IV q6h
:* Preferred regimen (immunocomppromised host): ([[Vancomycin]] 0.5 g IV q6h {{and}} [[Cefotaxime]] 2 g IV q6h) {{or}} [[Ceftizoxime]] 4 g IV q8h {{or}} [[Piperacillin]] 3 g IV q4h
* '''Extension of osteomyelitis from prevertebral space infection'''
:* Causative pathogens
::* Staphylococcus
::* Facultative gram-negative bacilli
:* Preferred regimen (immunocompetent host): ([[Nafcillin]] 1.5 g IV q4–6h {{and}} [[Metronidazole]] 0.5 g IV q6h) {{or}} [[Ciprofloxacin]] 200 mg q12h
:* Preferred regimen (immunocomppromised host): ([[Vancomycin]] 0.5 g IV q6h {{and}} [[Cefotaxime]] 2 g IV q6h) {{or}} [[Ceftizoxime]] 4 g IV q8h {{or}} [[Imipenem]] 500 mg IV q6h
* '''Pott's puffy tumor (frontal osteitis)'''
:* Causative pathogens
::* Streptococcus pyogenes
::* Fusobacterium
::* Peptostreptococcus
::* Other oral anaerobes
:* Preferred regimen (immunocompetent host): [[Penicillin G]] 2–4 MU IV q4–6h {{or}} ([[Ciprofloxacin]] 200 mg q12h {{and}} [[Metronidazole]] 0.5 g IV q6h) {{or}} [[Gatifloxacin]] 400 mg IV q24h {{or}} [[Clindamycin]] 600 mg IV q6h
:* Preferred regimen (immunocomppromised host): [[Cefotaxime]] 2 g IV q6h {{or}} [[Ceftizoxime]] 4 g IV q8h {{or}} [[Piperacillin]] 3 g IV q4h {{or}} [[Imipenem]] 500 mg IV q6h {{or}} [[Imipenem]] 500 mg IV q6h {{or}} [[Gatifloxacin]] 400 mg IV q24h
* '''Malignant otitis media'''
:* Causative pathogens
::* Pseudomonas aeruginosa
:* Preferred regimen (immunocompetent host): [[Ciprofloxacin]] 200 mg q12h {{or}} ([[Tobramycin]] 2 mg/kg IV q8h {{and}} [[Ceftazidime]] 2 g IV q6h) {{or}} [[Piperacillin]] 3 g IV q4h {{or}} [[Imipenem]] 500 mg IV q6h
:* Preferred regimen (immunocomppromised host): ([[Tobramycin]] 2 mg/kg IV q8h {{and}} [[Ceftazidime]] 2 g IV q6h) {{or}} [[Piperacillin]] 3 g IV q4h {{or}} [[Imipenem]] 500 mg IV q6h {{or}} [[Imipenem]] 500 mg IV q6h
* '''Petrous osteitis'''
:* Causative pathogens
::* Pseudomonas aeruginosa
:* Preferred regimen (immunocompetent host): [[Ciprofloxacin]] 200 mg q12h {{or}} ([[Tobramycin]] 2 mg/kg IV q8h {{and}} [[Ceftazidime]] 2 g IV q6h) {{or}} [[Piperacillin]] 3 g IV q4h {{or}} [[Imipenem]] 500 mg IV q6h
:* Preferred regimen (immunocomppromised host): ([[Tobramycin]] 2 mg/kg IV q8h {{and}} [[Ceftazidime]] 2 g IV q6h) {{or}} [[Piperacillin]] 3 g IV q4h {{or}} [[Imipenem]] 500 mg IV q6h {{or}} [[Imipenem]] 500 mg IV q6h
* '''Septic jugular thrombophlebitis (Lemierre syndrome)'''
:* Causative pathogens
::* Fusobacterium
::* Viridans and other streptococci
::* Staphylococcus
::* Peptostreptococcus
::* Bacteroides
::* Other oral anaerobes
:* Preferred regimen (immunocompetent host): ([[Penicillin G]] 2–4 MU IV q4–6h {{and}} [[Metronidazole]] 0.5 g IV q6h) {{or}} [[Ampicillin-Sulbactam]] 2 g IV q4h {{or}} [[Clindamycin]] 600 mg IV q6h
:* Preferred regimen (immunocomppromised host): [[Cefotaxime]] 2 g IV q6h {{or}} [[Ceftizoxime]] 4 g IV q8h {{or}} [[Piperacillin]] 3 g IV q4h {{or}} Imipenem 500 mg IV q6h {{or}} [[Imipenem]] 500 mg IV q6h {{or}} [[Gatifloxacin]] 400 mg IV q24h


===Tonsillitis===
===Tonsillitis===

Revision as of 07:04, 11 June 2015

Epiglottitis

Jugular vein phlebitis

  • Septic jugular thrombophlebitis (Lemierre's syndrome)[1]
  • Causative pathogens
  • Fusobacterium
  • Viridans and other streptococci
  • Staphylococcus
  • Peptostreptococcus
  • Bacteroides
  • Other oral anaerobes

Laryngitis

Lemierre's syndrome

  • Septic jugular thrombophlebitis (Lemierre's syndrome)[2]
  • Causative pathogens
  • Fusobacterium
  • Viridans and other streptococci
  • Staphylococcus
  • Peptostreptococcus
  • Bacteroides
  • Other oral anaerobes

Ludwig's angina

  • Ludwig's angina[3]
  • Causative pathogens
  • Viridans and other streptococci
  • Peptostreptococcus
  • Bacteroides
  • Other oral anaerobes

Parapharyngeal space infection

  • Parapharyngeal space infection[4]
  • Causative pathogens
  • Viridans and other streptococci
  • Staphylococcus
  • Peptostreptococcus
  • Bacteroides
  • Other oral anaerobes

Pharyngitis, diphtheria

Pharyngitis, streptococcal

Sinusitis, Acute

Sinusitis, Chronic

Sinusitis, Post-intubation

Sinusitis, Treatment failure

Stomatitis

Stomatitis, aphthous

Stomatitis, herpetic

Submandibular space infection

  • Submandibular space infections including Ludwig angina[5]
  • Causative pathogens
  • Viridans and other streptococci
  • Peptostreptococcus
  • Bacteroides
  • Other oral anaerobes

Tonsillitis

Ulcerative gingivitis

Vincent's angina

  1. ↑ Hall, Jesse (2015). Principles of critical care. New York: McGraw-Hill Education. ISBN 978-0071738811.
  2. ↑ Hall, Jesse (2015). Principles of critical care. New York: McGraw-Hill Education. ISBN 978-0071738811.
  3. ↑ Hall, Jesse (2015). Principles of critical care. New York: McGraw-Hill Education. ISBN 978-0071738811.
  4. ↑ Hall, Jesse (2015). Principles of critical care. New York: McGraw-Hill Education. ISBN 978-0071738811.
  5. ↑ Hall, Jesse (2015). Principles of critical care. New York: McGraw-Hill Education. ISBN 978-0071738811.
Retrieved from "https://www.wikidoc.org/index.php?title=Sandbox_ID_Upper_Respiratory_Tract&oldid=1109171"